Literature DB >> 11307370

Source control in the management of sepsis.

M F Jimenez1, J C Marshall.   

Abstract

The process of surgical decision making is based on both general principles that are amenable to evaluation using rigorous techniques of clinical research and the intangible element of surgical judgment that seeks to apply those principles to the care of an individual patient. The role of surgical judgment is inescapable, even though it is intrinsically subjective and recalcitrant to objective evaluation, for a host of factors modify the application of principle in each patient, and render the circumstances of a given problem sufficiently distinctive, that evidence must be tempered with common sense. We have tried to provide, through an evidence-based approach to a series of questions, the rationale for the basic principles that should guide the clinician in initiating or modifying source control, recognizing that sound clinical judgement demands, at times, that these be set aside. In the individual patient, evidence of clinical improvement is the most important marker of the approach selected. Evaluation of the adequacy of source control in the critically ill patient can be difficult. As with other modes of anti-infective therapy, effective source control measures are expected to result in clinical improvement, reflected in: Resolution of clinical signs of sepsis or systemic inflammation. Bacteriological resolution. Evidence of reversal of the metabolic sequelae of infection, with normal progression of wound healing, reflected in the formation of granulation tissue, and epithelialization. Radiographic evidence of control of an infectious focus. Prevention of further organ dysfunction, and resolution of existing organ dysfunction. Survival. Evaluation of the adequacy of source control may necessitate planned reoperation. The adequacy of débridement of necrotizing soft-tissue infections can be assessed by repeat exploration under general anesthesia, continuing the process until there is evidence of healthy granulation tissue throughout the wound. Planned reexploration is also indicated for patients with diffuse intestinal ischemia to ensure bowel viability. The appropriate interventions to determine the adequacy of source control are dictated by the clinical circumstances. A residual or recurrent abscess can usually be demonstrated by CT or ultrasound examination, while resolution of an abscess cavity can be monitored using sinograms. The diagnosis of persistent or evolving tissue necrosis is guided by the clinical setting. Retroperitoneal necrosis can be detected by CT, while sigmoid ischemia following aortic aneurysmectomy can be evaluated by sigmoidoscopy. Occasionally diagnostic peritoneal lavage assists in establishing a diagnosis of gut ischemia; the lavage fluid appears bloody with established ischemia. The diagnosis of an infected foreign body requires an appropriate history and is supported by recurrent bacteremia or by positive cultures drawn retrograde through an indwelling vascular or peritoneal dialysis catheter. Finally, ongoing contamination from a breach of the gastrointestinal tract can be documented by appropriate contrast studies. The general principles that guide the use of source control techniques in the management of the patient with severe sepsis or septic shock are readily articulated. Their implementation in practice, however, is more complex, and does not, as a rule, lend itself to simple algorithms that are applicable in all cases. Moreover evidence-based support for these principles is weak. In the final analysis, the elusive process of experienced surgical judgement is invaluable for all but the most straightforward problems.

Entities:  

Mesh:

Year:  2001        PMID: 11307370     DOI: 10.1007/pl00003797

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Source control for surgical infections.

Authors:  Moshe Schein; John Marshall
Journal:  World J Surg       Date:  2004-06-08       Impact factor: 3.352

Review 2.  Biochemical transformation of bacterial lipopolysaccharides by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-12-18       Impact factor: 5.157

3.  Empirical antibiotic therapy of sepsis in surgical intensive care unit.

Authors:  Ljiljana Mihaljević; Slobodan Mihaljević; Ivan Vasilj; Semra Cavaljuga; Fadila Serdarević; Ivan Soldo
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

4.  Does the urgency of endoscopic retrograde cholangiopancreatography (ercp)/percutaneous biliary drainage (pbd) impact mortality and disease related complications in ascending cholangitis? (deim-i study).

Authors:  Shaffer R S Mok; Christie L Mannino; Jessica Malin; Matthew E Drew; Patricia Henry; Punitha Shivaprasad; Barry Milcarek; Adam B Elfant; Thomas A Judge
Journal:  J Interv Gastroenterol       Date:  2012-10-01

Review 5.  Current understanding in source control management in septic shock patients: a review.

Authors:  Leonel Lagunes; Belen Encina; Sergio Ramirez-Estrada
Journal:  Ann Transl Med       Date:  2016-09

Review 6.  Biochemical Transformation of Bacterial Lipopolysaccharide by acyloxyacyl hydrolase reduces host injury and promotes recovery.

Authors:  Robert S Munford; Jerrold P Weiss; Mingfang Lu
Journal:  J Biol Chem       Date:  2020-10-26       Impact factor: 5.157

7.  Accuracy of point of care ultrasound to identify the source of infection in septic patients: a prospective study.

Authors:  Francesca Cortellaro; Laura Ferrari; Francesco Molteni; Paolo Aseni; Marta Velati; Linda Guarnieri; Katia Barbara Cazzola; Silvia Colombo; Daniele Coen
Journal:  Intern Emerg Med       Date:  2016-05-28       Impact factor: 3.397

8.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

9.  Persistent bacteremia in the absence of defined intravascular foci: clinical significance and risk factors.

Authors:  M Y Chowers; B Gottesman; M Paul; M Weinberger; S Pitlik; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-25       Impact factor: 3.267

Review 10.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.